InMed Pharmaceuticals Inc. (OTCMKTS:IMLFF – Get Free Report)’s share price shot up 4.7% during trading on Tuesday . The stock traded as high as $0.28 and last traded at $0.27. 225,548 shares traded hands during mid-day trading, an increase of 1,884% from the average session volume of 11,369 shares. The stock had previously closed at $0.26.
InMed Pharmaceuticals Stock Up 4.7 %
The firm has a fifty day moving average price of $0.33 and a 200-day moving average price of $0.38.
About InMed Pharmaceuticals
InMed Pharmaceuticals Inc, a clinical stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company's lead product is INM-755, a cannabinol topical cream, which is in a second Phase I clinical trials for the treatment of epidermolysis bullosa. The company is also involved in developing INM-088, which is in preclinical studies for the treatment of glaucoma; and INM-405 for the treatment of orofacial pain.
See Also
- Five stocks we like better than InMed Pharmaceuticals
- Canadian Penny Stocks: Can They Make You Rich?
- Garmin Navigates to New Highs Driven By Wearables Trend
- What is the NASDAQ Stock Exchange?
- Pinterest Prospers From AI Boosting Shop-Ability and Relevance
- ESG Stocks, What Investors Should Know
- AbbVie Tracking for New Highs in 2024
Receive News & Ratings for InMed Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InMed Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
